147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
NORMAL SEARCH
ADVANCED SEARCH
More posts
BIO23231-D1

Methods for the diagnosis, treatment and analysis ofnlrp3-associated

Using NLRP3-deficient U937 cells reconstituted with doxycycline-inducible NLRP3 variants in response to NLRP3 induction, the present inventors have […]

Read more

You might also be interested in

BIO23509-T1

Methods of treating familial adenomatous polyposis

Familial adenomatous polyposis (FAP) patients harbor mutations in the APC gene and will develop […]

Read more
BIO21512-T1

Engraftment of engineered mesenchymal stromal

Dendritic cells (DCs) control the activation and infiltration of CD8+ T cells within the tumor […]

Read more
BIO24003-T1

Composition comprising furin-inhibited car

CAR macrophages (CAR-M) can phagocyte tumor cells expressing a target antigen. It is herein shown […]

Read more
BIO1634102-T1

Methods and pharmaceutical compositions for

Targeting immune checkpoints, such as Programmed cell Death 1 (PD1), has improved survival in cancer […]

Read more
BIO22194-T1

Inhibitor of the heterochromatin protein 1 (hp1)

The present invention relates to a treatment of Th cell-associated disorders. Here, the
inventors […]

Read more
BIO20377-T1

Methods and pharmaceutical compositions for

Tumour-specific molecular targets and alternative therapeutic strategies for triplenegative breast […]

Read more
BIO17187-T1

Method for treating cancer

The present invention relates to a method of treating HER2/
EU overexpressing cancers. The […]

Read more
BIO23521-T1

Methods of treating cancer combining uros

Thanks to its very high genome-editing efficiency, CRISPR-Cas9 technology could be a promising […]

Read more
BIO22282-T1

Garp as a biomarker and biotarget in t-cell

The present study of the regulatory T phenotype of Sézary cells led to the discovery of the […]

Read more
BIO2114501-T1

Methods for the diagnosis and treatment of t

T-cell malignancies are a broad, heterogenous group of diseases and include T-cell lymphomas and […]

Read more
BIO24047-T1

Methods and pharmaceutical composition for

Inventors demonstrated that an epigenetic regulator CBX3 antagonizes IFNγ signalling via directly […]

Read more
BIO22280-T1

Methods for the diagnosis and treatment of acute

The present invention relates to a method of treating acute lymphoblastic leukemia in a patient in […]

Read more